Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)

China · Delayed Price · Currency is CNY

13.65

-0.06 (-0.44%)

At close: Feb 13, 2026

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
In Vitro Diagnostics - Testing Reagents	651.83M
In Vitro Diagnostics - Testing Reagents Growth	25.73%
In Vitro Diagnostics - Testing Equipment	259.63M
In Vitro Diagnostics - Testing Equipment Growth	-16.36%
Treatment and Rehabilitation - Medical Products	197.57M
Treatment and Rehabilitation - Medical Products Growth	-31.35%
Treatment and Rehabilitation - Household Products	22.46M
Treatment and Rehabilitation - Household Products Growth	36.29%
Other Business	16.55M
Other Business Growth	31.57%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	759.20M
China Growth	-6.16%
Overseas	372.29M
Overseas Growth	14.87%